Mechanisms of cannabidiol (CBD) in cancer treatment: A review

CG Heider, SA Itenberg, J Rao, H Ma, X Wu - Biology, 2022 - mdpi.com
Simple Summary Emerging evidence suggests positive outcomes from the use of CBD as a
cancer treatment. CBD can relieve cancer pain and ease the side effects of chemotherapy; …

[HTML][HTML] Animal-derived products in science and current alternatives

AC Duarte, EC Costa, HAL Filipe, SM Saraiva… - Biomaterials …, 2023 - Elsevier
More than fifty years after the 3Rs definition and despite the continuous implementation of
regulatory measures, animals continue to be widely used in basic research. Their use …

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics

T Buchtova, D Lukac, Z Skrott, K Chroma… - International Journal of …, 2023 - mdpi.com
Cannabidiol (CBD) is an easily accessible and affordable Marijuana (Cannabis sativa L.)
plant derivative with an extensive history of medical use spanning thousands of years …

Exosomal delivery of cannabinoids against cancer

S Kaur, A Nathani, M Singh - Cancer letters, 2023 - Elsevier
Exosomes are extracellular vesicles (EVs) originating from endosomes that play a role in
cellular communication. These vesicles which mimic the parental cells that release them are …

The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice

AK Kalvala, R Nimma, A Bagde, SK Surapaneni… - Biochimie, 2023 - Elsevier
The significant resistance to currently available chemotherapeutics makes treatment for
TNBC a key clinical concern. Herein, we studied the anti-cancer potentials of synthetic …

Reactive oxygen species as mediators of disease progression and therapeutic response in colorectal cancer

NJ Lyons, R Giri, J Begun, D Clark, D Proud… - Antioxidants & Redox …, 2023 - liebertpub.com
Significance: Reactive oxygen species (ROS) are critical to normal cellular function with
redox homeostasis achieved by balancing ROS production with removal through …

[HTML][HTML] Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex

L Gu, X Jin, H Liang, C Yang, Y Zhang - Pharmacological Research, 2023 - Elsevier
Oral multitarget tyrosine kinase inhibitors (TKIs), such as sorafenib, which suppress tumor
cell proliferation and tumor angiogenesis, have been approved to treat patients with …

Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data

K Xing, B Zhang, Z Wang, Y Zhang, T Chai, J Geng… - Cells, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is a highly heterogeneous disease with different
molecular subtypes. Although progress has been made, the identification of TNBC subtype …

[HTML][HTML] Lipopolysaccharide and lipoteichoic acid regulate the PI3K/AKT pathway through osteopontin/integrin β3 to promote malignant progression of non-small cell …

M Zhang, Y Sun, Y Zhang, Z Wang… - Journal of Thoracic …, 2023 - ncbi.nlm.nih.gov
Background Lung cancer (LC) is a malignancy with one of the highest mortality rates.
Respiratory microbiota is considered to play a key role in the development of LC, but the …

Cannabidiol and Beta-Caryophyllene Combination Attenuates Diabetic Neuropathy by Inhibiting NLRP3 Inflammasome/NFκB through the AMPK/sirT3/Nrf2 Axis

I Khan, S Kaur, AK Rishi, B Boire, M Aare, M Singh - Biomedicines, 2024 - mdpi.com
Background: In this study, we investigated in detail the role of cannabidiol (CBD), beta-
caryophyllene (BC), or their combinations in diabetic peripheral neuropathy (DN). The key …